Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease - A case-control study from the Vaccine Safety Datalink Project
Rl. Davis et al., Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease - A case-control study from the Vaccine Safety Datalink Project, ARCH PED AD, 155(3), 2001, pp. 354-359
Context: A link between measles virus-containing vaccines and inflammatory
bowel disease (IBD) has been suggested by recent studies.
Objective: To address whether receipt or timing of measles-containing vacci
ne (MCV) increases risk for IBD.
Design: A case-control study.
Setting: Four large health maintenance organizations (HMOs) that are part o
f the Centers for Disease Control and Prevention's Vaccine Safety Datalink
project.
Patients or Other Participants: A total of 155 persons with codes from Inte
rnational Classification of Diseases, Ninth Revision specific for IBD, born
between 1958 and 1989 and enrolled from birth to the onset of disease, wer
e identified. Up to 5 controls were matched by sex, HMO, and birth year.
Intervention: None.
Main Outcome Measures: Risk for IBD, Crohn's disease, and ulcerative coliti
s.
Results: Past vaccination was not associated with an increased risk for Cro
hn's disease (odds ratio [OR] for measles-mumps-rubella vaccine [MMR], 0.4;
95% confidence interval [CI], 0.08-2.0), ulcerative colitis (OR, 0.8; 95%
CI, 0.18-3.56), or IBD (OR, 0.59; 95% CI, 0.21-1.68). Risk for IBD was not
increased among children vaccinated who were younger than 12 months (OR for
MMR, 0.61; 95% CI, 0.15-2.45) or aged 12 to 18 months (OR, 0.86; 95% CI, 0
.28-2.59) relative to unvaccinated children. Children vaccinated with MMR w
ho were older than 18 months were at significantly decreased risk for IBD (
OR, 0.16; 95% CI, 0.04-0.68). Neither past vaccination nor age at vaccinati
on with other MCV was associated with increased risk for Crohn's disease, u
lcerative colitis, or IBD. Risk for Crohn's disease, ulcerative colitis, or
IBD was not elevated in the time immediately following vaccination with ei
ther vaccine.
Conclusions: Vaccination with MMR or other MCV, or the timing of vaccinatio
n early in life, did not increase the risk for IBD.